Ramon Albarran

Dr. Ramon Albarran

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 December 2025 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Open access
VCVictor Javier Ceseña‐Báez
Victor Javier Ceseña‐Báez
RARamon Albarran
Ramon Albarran
AAAriana Alvárez‐Acedo
Ariana Alvárez‐Acedo
MMMatthew D. Martens
Matthew D. Martens
BSBrad S. Sutton
Brad S. Sutton
IGIgnacio Garcia‐Bolao
Ignacio Garcia‐Bolao
Introduction: Safe and effective left atrial (LA) access is a critical step in catheter ablation procedures. While radiofrequency wire (RFW)‐based transseptal puncture (TSP) offers advantages over mechanical needle (MN) techniques, adoption in Europe has been limited due to concerns about the need for costly adjunctive imaging. This study evaluated the feasibility of using RFW‐based TSP within fluoroscopy‐only pulsed field ablation (PFA) procedures. Methods: A retrospective, single‐center chart review of consecutive PFA cases was conducted. TSP was performed using either an MN or RFW, with MN serving as a feasibility benchmark. All procedures used the pentaspline PFA system under standard‐of‐care protocols, with fluoroscopy as the primary imaging modality. Results: A total of 617 PFA procedures were analyzed (435 RFW, 182 MN). Baseline characteristics were similar. LA access was successful in all RFW cases, with no significant difference in complication rates. Notably, no RFW cases required adjunctive echocardiography, compared to three in the MN group (0% vs. 1.6%, p < 0.01). Procedural times and fluoroscopy exposure were comparable. In patients with prior TSP, RFW enabled significantly faster and more consistent access than MN (8.1 ± 3.9 min vs. 11.1 ± 5.8 min, p < 0.01). Conclusion: Purpose‐built RFW systems demonstrated comparable safety and efficacy to MN‐based devices in fluoroscopy‐only PFA workflows, with added efficiency and predictability in complex anatomies. These findings suggest that the benefits of RFW can be realized without reliance on costly imaging modalities.

6 August 2025 in Biomedicines
Verified
Journal Article
Open access
PDF file
JIJavier Ibero
Javier Ibero
IGIgnacio García-Bolao
Ignacio García-Bolao
GBGabriel Ballesteros
Gabriel Ballesteros
PRPablo Ramos
Pablo Ramos
RARamon Albarran
Ramon Albarran
IDInes Diaz-Dorronsoro
Ines Diaz-Dorronsoro
Background: Atrial fibrosis is a key contributor to atrial cardiomyopathy and can be assessed invasively using mean left atrial voltage (MLAV) from electroanatomical mapping. However, the invasive nature of this procedure limits its clinical applicability. Machine learning (ML), particularly regression tree-based models, may offer a non-invasive approach for predicting MLAV using clinical and echocardiographic data, improving non-invasive atrial fibrosis characterisation beyond current dichotomous classifications. Methods: We prospectively included and followed 113 patients with paroxysmal or persistent atrial fibrillation (AF) undergoing pulmonary vein isolation (PVI) with ultra-high-density voltage mapping (uHDvM), from whom MLAV was estimated. Standardised two-dimensional transthoracic echocardiography was performed before ablation, and clinical and echocardiographic variables were analysed. A regression tree model was constructed using the Classification and Regression Trees—CART-algorithm to identify key predictors of MLAV. Results: The regression tree model exhibited moderate predictive accuracy (R2 = 0.63; 95% CI: 0.55–0.71; root mean squared error = 0.90; 95% CI: 0.82–0.98), with indexed minimum LA volume and passive emptying fraction emerging as the most influential variables. No significant differences in AF recurrence-free survival were found among MLAV tertiles or model-based generated groups (log-rank p = 0.319 and p = 0.126, respectively). Conclusions: We present a novel ML-based regression tree model for non-invasive prediction of MLAV, identifying minimum LA volume and passive emptying fraction as the most significant predictors. This model offers an accessible, non-invasive tool for refining atrial cardiomyopathy characterisation by reflecting the fibrotic substrate as a continuum, a crucial advancement over existing dichotomous approaches to guide tailored therapeutic strategies.

24 May 2024 in EP Europace
Verified
Journal Article
Open access
RARamon Albarran
Ramon Albarran
VRV Rodaev
V Rodaev
FCF De La Torre Carazo
F De La Torre Carazo
PAP Ramos Ardanaz
P Ramos Ardanaz
MYM Garcia De Yebenes
M Garcia De Yebenes
IGI Garcia-Bolao
I Garcia-Bolao
Background: Frequent premature ventricle complex (PVC) could induce cardiomyopathy in some patient. PVC ablation by radiofrequency (RF) is a well-stablished procedure in high density PVC patients and results are consistent and robust in literature, with somewhat differing success rates reported. Catheter ablation of radiofrequency guided by ultra-high density mapping systems (UHDMS), enable a much more accurate reconstruction of the site of origin (SOO). Furthermore, we obtained this anatomic recreation with the analysis of a few number of beats. The UHDMS have demonstrated to be feasible and safe in a wide range / large spectrum of arrhythmic substrates, however, there is lack of evidence of its usefulness in the ablation of PVC. Purpose: To determine the safety and utility, both in the acute phase and in the short-medium term, of employing a UHDMS in PVC catheter ablation in a retrospective cohort of patients treated at a single centre. Methods: Catheter ablation procedures guided by an UHDMS carried out from July 2015 to January 2021 in a single-center of Spain were retrospectively included. The primary outcomes analyzed were: acute success rate, short-medium success rate (6-month efficacy after ablation), and complication rate related to the procedure. Results: One hundred and two procedures, corresponding to 92 patients (mean age 59 ± 14 years, 63% male, 74% without cardiomyopathy, mean LVEF of 60%), were analyzed. The acute success rate was 93%. According the SOO, the lowest acute success rate was PVC from epicardial level (LV Summit) (75%). At 6-month follow-up after the first procedure, the short-medium success rate was up to 84% (no recurrence of the PVC ablated). There were three acute complications related to the procedure (complication rate 2,94%). In 19% (21 out 102) of the procedures, at least two arrhythmic substrates were successfully ablated in a single intervention. Conclusion: Catheter ablation guided by an UHDMS showed an excellent safety profile in PVC ablation procedures. Beyond this minor complication rate, this type of technique has improved acute and short-term success rates. This allows us to assert that this type of technique grants a very high success rate and improves previously results. Last but not least, this new approach was useful and accurate in complex patients, providing good results in ablation procedures of two or more arrhythmic substrates without altering the safety profile.

24 May 2024 in EP Europace
Verified
Journal Article
Open access
PDF file
RARamon Albarran
Ramon Albarran
JCJ Barragan Campos
J Barragan Campos
PAP Ramos Ardanaz
P Ramos Ardanaz
MCM Garcia De Yebenes Castro
M Garcia De Yebenes Castro
IGI Garcia-Bolao
I Garcia-Bolao
Background: The relationship between oncological events and cardiovascular pathologies is a subject still widely discussed. Certain chemotherapy drugs, including alkylating agents, anthracyclines, taxanes, and topoisomerase II inhibitors have proven to possess arrhythmic and cardiotoxic capabilities. There is enough evidence to suggest an association between oncological events and the appearance of newly onset AF, but there is little to no scientific literature about the management of these patients and the outcome of normal therapeutically procedures. Purpose: This study assess if oncocardiological patients with AF should be considered a risk group when planning to undergo catheter ablation for the arrhythmia treatment. Methods: The studied population was based on the data recollection from the electrophysiology department and consisted of patients with AF intervened by radiofrequency catheter ablation. All the procedures were conducted between January 1st 2019 and December 31st 2022. Among 138 participants enrolled for this study, 68 of them had either recent history of oncological events (maximum of 5 years cancer-free). The control group had no previous nor active history of cancer. The cohort with the desired exposure (cancer patients) was compared with a cancer-free group. Two primary outcomes were measured: procedure related complications, and first AF recurrence within the first 12 months. Complications were categorized according to two dichotomous variables: the existence of acute complications directly during the procedure or within the first 12 hours after the end of the procedure, and the occurrence of self-limited arrhythmic events during the blanking period. Results: When compared as dichotomous variables (yes/no) with Fisher’s exact test, no statistical significance was observed between the studied cohort and control for complications and events during blanking. The proportion of patients free of sustained episodes of AF at 12 months was 52,9% in the oncologic group and 77,9% in the Control group (P = 0.003; RR of 3.14; 95% CI 1.5 - 6.6) for the oncologic group. When not adjusted by any other factor, association with Cancer was shown (HR 2.43; P =0.005; 95% CI 1.3 – 4.4) for recurrence of arrhythmic events. The regression model with Kaplan-Meier method shows the overall 12-month survival in two groups and the difference between the two survival curves was statistically significant (P=0.0016). Conclusion: Oncocardiological patients have demonstrated a significantly higher incidence in post-ablational recurrence when compared with a similar cancer-free control group. Results found in acute and chronic procedural complications were similar in both cohorts.

4 December 2022 in Journal of Arrhythmia
Verified
Journal Article
Open access
RARamon Albarran
Ramon Albarran
ÁGÁlvaro Riesgo García
Álvaro Riesgo García
PRPablo Ramos
Pablo Ramos
IGIgnacio García‐Bolao
Ignacio García‐Bolao